A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Israel
RecruitingPHASE3

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Chronic Inflammatory Demyelinating Polyneuropathy

Locations
  • Alabama Neurology Associates- Site Number : 8400019, Homewood, Alabama, United States
  • Honor Health Scottsdale Osborn Medical Center- Site Number : 8400014, Scottsdale, Arizona, United States
  • Keck School of Medicine of University of Southern California- Site Number : 8400002, Los Angeles, California, United States
  • University of California Irvine Medical Center- Site Number : 8400007, Orange, California, United States
  • Yale University School of Medicine- Site Number : 8400018, New Haven, Connecticut, United States
  • AdventHealth Orlando- Site Number : 8400006, Orlando, Florida, United States
  • AdventHealth Site Number : 8400006, Orlando, Florida, United States
  • NorthShore University Health System - Glenbrook Hospital- Site Number : 8400024, Glenview, Illinois, United States
  • University of Kansas Medical Center- Site Number : 8400010, Kansas City, Kansas, United States
  • Ochsner Medical Center - Jefferson Highway- Site Number : 8400030, New Orleans, Louisiana, United States
  • Johns Hopkins Hospital- Site Number : 8400015, Baltimore, Maryland, United States
  • Massachusetts General Hospital- Site Number : 8400009, Boston, Massachusetts, United States
  • Henry Ford Hospital- Site Number : 8400025, Detroit, Michigan, United States
  • Michigan State University- Site Number : 8400038, East Lansing, Michigan, United States
  • Washington University School of Medicine - Siteman Cancer Center- Site Number : 8400037, St Louis, Missouri, United States
  • Dent Neurologic Institute - Amherst- Site Number : 8400039, Amherst, New York, United States
  • Hospital for Special Surgery- Site Number : 8400041, New York, New York, United States
  • Columbia University Irving Medical Center- Site Number : 8400003, New York, New York, United States
  • Raleigh Neurology Associates- Site Number : 8400043, Raleigh, North Carolina, United States
  • University of Cincinnati Medical Center- Site Number : 8400020, Cincinnati, Ohio, United States
  • University Hospitals Cleveland Medical Center- Site Number : 8400033, Cleveland, Ohio, United States
  • Penn Medicine: University of Pennsylvania Health System- Site Number : 8400022, Philadelphia, Pennsylvania, United States
  • Austin Neuromuscular Center- Site Number : 8400040, Austin, Texas, United States
  • University of Vermont Medical Center- Site Number : 8400012, Burlington, Vermont, United States
  • University of Virginia- Site Number : 8400023, Charlottesville, Virginia, United States
  • Investigational Site Number : 0320001, Buenos Aires, Argentina
  • Investigational Site Number : 0320002, Buenos Aires, Argentina
  • Investigational Site Number : 0320003, Buenos Aires, Argentina
  • Investigational Site Number : 0560002, Ghent, Belgium
  • Investigational Site Number : 0560001, Leuven, Belgium
  • L2IP - Instituto de Pesquisas Clínicas- Site Number : 0760006, Brasília, Federal District, Brazil
  • Instituto de Neurologia de Curitiba - Ecoville- Site Number : 0760007, Curitiba, Paraná, Brazil
  • InsCer - Instituto do Cérebro da PUCRS- Site Number : 0760002, Porto Alegre, Rio Grande do Sul, Brazil
  • PSEG Centro de Pesquisa Clínica- Site Number : 0760009, São Paulo, Brazil
  • Investigational Site Number : 1240003, London, Ontario, Canada
  • Investigational Site Number : 1240006, Montreal, Quebec, Canada
  • Investigational Site Number : 1240001, Québec, Quebec, Canada
  • Investigational Site Number : 1560013, Beijing, China
  • Investigational Site Number : 1560010, Beijing, China
  • Investigational Site Number : 1560005, Beijing, China
  • Investigational Site Number : 1560017, Beijing, China
  • Investigational Site Number : 1560009, Changsha, China
  • Investigational Site Number : 1560011, Chengdu, China
  • Investigational Site Number : 1560002, Fuzhou, China
  • Investigational Site Number : 1560012, Guangzhou, China
  • Investigational Site Number : 1560007, Guangzhou, China
  • Investigational Site Number : 1560014, Hangzhou, China
  • Investigational Site Number : 1560016, Jiazhuang, China
  • Investigational Site Number : 1560008, Jinan, China
  • Investigational Site Number : 1560015, Nanchang, China
  • Investigational Site Number : 1560001, Shanghai, China
  • Investigational Site Number : 1560003, Wuhan, China
  • Investigational Site Number : 1560006, Wuhan, China
  • Investigational Site Number : 1560004, Xi'an, China
  • Investigational Site Number : 2030004, Brno, Czechia
  • Investigational Site Number : 2030003, Hradec Králové, Czechia
  • Investigational Site Number : 2030005, Ostrava, Czechia
  • Investigational Site Number : 2030002, Pardubice, Czechia
  • Investigational Site Number : 2030001, Prague, Czechia
  • Investigational Site Number : 2080002, Aarhus, Denmark
  • Investigational Site Number : 2080001, Copenhagen, Denmark
  • Investigational Site Number : 2500001, Le Kremlin-Bicêtre, France
  • Investigational Site Number : 2500002, Marseille, France
  • Investigational Site Number : 2500005, Nice, France
  • Investigational Site Number : 2500003, Paris, France
  • Investigational Site Number : 2760003, Berlin, Germany
  • Investigational Site Number : 2760008, Bochum, Germany
  • Investigational Site Number : 2760006, Göttingen, Germany
  • Investigational Site Number : 2760005, Hanover, Germany
  • Investigational Site Number : 2760001, Münster, Germany
  • Investigational Site Number : 3480003, Budapest, Hungary
  • Investigational Site Number : 3480004, Győr, Hungary
  • Investigational Site Number : 3480001, Szeged, Hungary
  • Investigational Site Number : 3760001, Haifa, Israel
  • Investigational Site Number : 3800001, Padua, Padova, Italy
  • Investigational Site Number : 3800002, Bologna, Italy
  • Investigational Site Number : 3920007, Amagasaki, Hyōgo, Japan
  • Investigational Site Number : 3920015, Yokohama, Kanagawa, Japan
  • Investigational Site Number : 3920012, Higashi-Matsuyama, Saitama, Japan
  • Investigational Site Number : 3920005, Kawagoe, Saitama, Japan
  • Investigational Site Number : 3920014, Yaizu, Shizuoka, Japan
  • Investigational Site Number : 3920008, Kodaira, Tokyo, Japan
  • Investigational Site Number : 3920010, Ōta-ku, Tokyo, Japan
  • Investigational Site Number : 3920001, Chiba, Japan
  • Investigational Site Number : 3920009, Saga, Japan
  • Investigational Site Number : 4840002, Chihuahua City, Mexico
  • Investigational Site Number : 4840001, Tlalnepantla, Mexico
  • Investigational Site Number : 5780001, Oslo, Norway
  • Investigational Site Number : 6200003, Braga, Portugal
  • Investigational Site Number : 6200005, Coimbra, Portugal
  • Investigational Site Number : 6200002, Lisbon, Portugal
  • Investigational Site Number : 6200001, Lisbon, Portugal
  • Investigational Site Number : 7240012, Santiago de Compostela, A Coruña [La Coruña], Spain
  • Investigational Site Number : 7240009, Barcelona, Barcelona [Barcelona], Spain
  • Investigational Site Number : 7240006, Sabadell, Barcelona [Barcelona], Spain
  • Investigational Site Number : 7240001, Barcelona, Catalunya [Cataluña], Spain
  • Investigational Site Number : 7240008, Majadahonda, Madrid, Spain
  • Investigational Site Number : 7240002, Pamplona, Navarre, Spain
  • Investigational Site Number : 7240003, Oviedo, Principality of Asturias, Spain
  • Investigational Site Number : 7240007, Málaga, Spain
  • Investigational Site Number : 7240010, Santa Cruz de Tenerife, Spain
  • Investigational Site Number : 7240004, Valencia, Spain
  • Investigational Site Number : 7520001, Stockholm, Sweden
  • Investigational Site Number : 7560001, Basel, Switzerland
  • Investigational Site Number : 7560003, Bern, Switzerland
  • Investigational Site Number : 1580003, Kaohsiung City, Taiwan
  • Investigational Site Number : 1580001, Taipei, Taiwan
  • Investigational Site Number : 1580002, Taipei, Taiwan
  • Investigational Site Number : 7920004, Bursa, Turkey (Türkiye)
  • Investigational Site Number : 7920001, Istanbul, Turkey (Türkiye)
  • Investigational Site Number : 7920002, Istanbul, Turkey (Türkiye)
  • Investigational Site Number : 7920003, Konya, Turkey (Türkiye)
  • Investigational Site Number : 8260007, London, England, United Kingdom
  • Investigational Site Number : 8260003, Inverness, Highland, United Kingdom
  • Investigational Site Number : 8260001, Oxford, Oxfordshire, United Kingdom